Chiesi Poland Sp. z o.o. is the Polish affiliate of Chiesi Group, an international pharmaceutical company focused on developing and commercializing modern therapeutic solutions. The company operates across several core therapeutic areas including respiratory medicine (with focus on asthma and COPD), neonatology, transplantology and rare diseases, complemented by pediatric-focused products, and maintains a portfolio of prescription medicines and selected OTC products and patient-support brands. Key assets include access to the wider Chiesi Groups R&D and international operating platform, including multiple research centers and a multi-country affiliate network, enabling clinical development, lifecycle management and specialized-market execution. Geographic reach is anchored in Poland, with the affiliate integrated into a global organization distributing pharmaceuticals across a large number of countries through international companies and partners. Strategically, Chiesi positions as an innovation-driven, patient-centered pharmaceutical group with a strong responsibility agenda, reinforced by B Corp certification and a benefit-oriented corporate model, and focuses on long-term value creation through R&D investment, portfolio specialization in complex and high-need therapeutic areas, and structured governance and transparency practices across markets.
Headquarters
Ul. Al. Aleje Jerozolimskie 134
Warsaw; Mazowieckie;
Postal Code: 02-305
Contact Details: Purchase the Chiesi Poland Sp. z o.o. report to view the information.
Website: http://www.chiesi.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service